TNF and arthritic joint disease: These findings reveal that MEK/ERK-dependent transcription factors that are downstream of TNFα, such as Egr-1, may be targets for therapeutic intervention to treat the pathophysiology of arthritis without disrupting other potential positive effects of TNFα.